Symbols

AQST

Aquestive·NASDAQ

--(--)

AQST Profile

Aquestive Therapeutics, Inc.

A company that developing orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies

Industry

Pharmaceutical

Established Date

Listing Date

07/25/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

147

Fiscal Year Ends

12-31

Website

aquestive.com

Security Type

Common stock

Office address

30 Technology Drive, Warren, NJ 07059

Business

Introduction

Aquestive Therapeutics, Inc., was incorporated in Delaware in January 2004. The company is a pharmaceutical company that advances medicines through innovative delivery technologies, focusing on developing alternatives to invasive standard therapies. It develops proprietary drug candidates including epinephrine prodrugs for anaphylactic shock and has licensed commercialized products manufactured by its factories.